Drexler H - Search Results

1

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E, Montalescot G. Beygui F, et al. Among authors: drexler h. Am J Cardiol. 2010 Sep 1;106(5):650-8. doi: 10.1016/j.amjcard.2010.04.019. Epub 2010 Jul 23. Am J Cardiol. 2010. PMID: 20723640 Clinical Trial.

2

Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.

Montalescot G, Drexler H, Gallo R, Pearson T, Thoenes M, Bhatt DL. Montalescot G, et al. Among authors: drexler h. Eur Heart J. 2009 Nov;30(22):2733-41. doi: 10.1093/eurheartj/ehp301. Epub 2009 Aug 21. Eur Heart J. 2009. PMID: 19700470 Clinical Trial.

3

Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.

Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. Kempf T, et al. Among authors: drexler h. J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60. doi: 10.1016/j.jacc.2007.04.091. Epub 2007 Aug 24. J Am Coll Cardiol. 2007. PMID: 17825714 Free article.

4

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.

Schieffer B, Bünte C, Witte J, Hoeper K, Böger RH, Schwedhelm E, Drexler H. Schieffer B, et al. Among authors: drexler h. J Am Coll Cardiol. 2004 Jul 21;44(2):362-8. doi: 10.1016/j.jacc.2004.03.065. J Am Coll Cardiol. 2004. PMID: 15261932 Free article. Clinical Trial.

5

Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.

Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, Siegbahn A, Venge P, Drexler H, Wallentin L. Wollert KC, et al. Among authors: drexler h. Circulation. 2007 Oct 2;116(14):1540-8. doi: 10.1161/CIRCULATIONAHA.107.697714. Epub 2007 Sep 11. Circulation. 2007. PMID: 17848615

6

Mechanism of coronary artery restenosis after stenting for acute myocardial infarction.

Schaefer A, Klein G, Fischer D, Meyer GP, Drexler H, Hausmann D. Schaefer A, et al. Among authors: drexler h. Am J Cardiol. 2004 Oct 15;94(8):1037-40. doi: 10.1016/j.amjcard.2004.06.062. Am J Cardiol. 2004. PMID: 15476620

7

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.

Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. Wollert KC, et al. Among authors: drexler h. Circulation. 2007 Feb 27;115(8):962-71. doi: 10.1161/CIRCULATIONAHA.106.650846. Epub 2007 Feb 5. Circulation. 2007. PMID: 17283261

8

One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.

Baumgart D, Klauss V, Baer F, Hartmann F, Drexler H, Motz W, Klues H, Hofmann S, Völker W, Pfannebecker T, Stoll HP, Nickenig G; SCORPIUS Study Investigators. Baumgart D, et al. Among authors: drexler h. J Am Coll Cardiol. 2007 Oct 23;50(17):1627-34. doi: 10.1016/j.jacc.2007.07.035. J Am Coll Cardiol. 2007. PMID: 17950142 Free article. Clinical Trial.

9

Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.

Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S, Wollert KC. Kempf T, et al. Among authors: drexler h. Circ Cardiovasc Genet. 2009 Jun;2(3):286-92. doi: 10.1161/CIRCGENETICS.108.824870. Epub 2009 Mar 31. Circ Cardiovasc Genet. 2009. PMID: 20031597

10

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, Kuskowski M, Cohn JN, Drexler H, Wollert KC. Anand IS, et al. Among authors: drexler h. Circulation. 2010 Oct 5;122(14):1387-95. doi: 10.1161/CIRCULATIONAHA.109.928846. Epub 2010 Sep 20. Circulation. 2010. PMID: 20855664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,278 results

Search Page